Dean Gregory
Fortune : 206 406 $ au 30/09/2026
Fortune : 206 406 $ au 30/09/2026
Mr. Dean A. Gregory is an Independent Director at Cerus Corp.
He is on the Board of Directors at Cerus Corp.
and Illinois Biotechnology Industry Organization.
Mr. Gregory was previously employed as a President-Global Commercial Operations by Fresenius Kabi Pharmaceuticals Holding, Inc. (United States), a Senior Vice President-Sales & Operations by Fenwal, Inc., and a VP-Business Development, Strategy & Marketing ROW by Baxter International, Inc. He received his undergraduate degree from the University of Illinois and an MBA from DePaul University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CERUS CORPORATION 0,04 % | 02/06/2026 | 86 725 ( 0,04 % ) | 206 406 $ | 30/09/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CERUS CORPORATION | Directeur/Membre du Conseil | 01/07/2024 |
Illinois Biotechnology Industry Organization
Illinois Biotechnology Industry Organization Miscellaneous Commercial ServicesCommercial Services Life science industry association | Directeur/Membre du Conseil | 20/01/2010 |
| Sociétés | Poste | Fin |
|---|---|---|
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States)
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 01/03/2024 |
Fenwal, Inc.
Fenwal, Inc. BiotechnologyHealth Technology Manufactures blood collection and transfusion systems | Directeur des opérations | 18/03/2010 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/02/2007 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 7 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Cerus Corp.
Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
DePaul University
DePaul University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fenwal, Inc.
Fenwal, Inc. BiotechnologyHealth Technology Manufactures blood collection and transfusion systems | Health Technology |
Illinois Biotechnology Industry Organization
Illinois Biotechnology Industry Organization Miscellaneous Commercial ServicesCommercial Services Life science industry association | Commercial Services |
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States)
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national